J&J applies for emergency use approval of COVID-19 vaccine in India

Johnson & Johnson has applied for emergency use approval of its coronavirus vaccine in India, the U.S. pharmaceutical giant said on Friday, moving a step closer to supplying the first single-dose COVID-19 shot to the country. The shot will be brought to India through a supply agreement with homegrown vaccine maker Biological E Ltd, J&J said in an emailed statement.